| Name | Designation | Appointment Date | Status | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Brian George Mcclelland
Appointed as Director since September 2023 |
Director | 15-Sep-2023 | Current | ||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Yoganjaneya Reddy Panem
Appointed as Director since June 2015 |
Director | 09-Jun-2015 | Current | ||||||||||||||||||||||||||||
|
Kajal Palan
Appointed as Additional Director since May 2024 |
Additional Director | 03-May-2024 | Current | ||||||||||||||||||||||||||||
|
Uta Kellermann Renton
Appointed as Director since September 2025 |
Director | 23-Sep-2025 | Current | ||||||||||||||||||||||||||||
People Timeline
Explore the timeline of key personnel in Apotex Pharmachem India Private Limited's leadership journey.
Loading...
Contact Details
- Address Site No. 1 A,Bommasandra Industrial Area, 1V Th Phase, Jigani Link Road,, Bangalore Karnataka, 562158, India
- Telephone Upgrade
- Email Upgrade
- Pin Code 562158
- Country India
- Website apotexpharmachem.com
- Social Media
Frequently Asked Questions
How can I contact Apotex Pharmachem India Private Limited?
You can contact Apotex Pharmachem India Private Limited through their registered address at Site No. 1 A,Bommasandra Industrial Area, 1V Th Phase, Jigani Link Road,, Bangalore Karnataka, 562158, India, or via their website at apotexpharmachem.com. Social media links are also provided where applicable.
Who are the current directors of Apotex Pharmachem India Private Limited?
The current directors of Apotex Pharmachem India Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- BRIAN GEORGE MCCLELLAND
- YOGANJANEYA REDDY PANEM
- Kajal Palan
- Uta Kellermann Renton
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.